COMMUNIQUÉS West-GlobeNewswire
-
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/01/2026 -
Gastro Center of Maryland Expands Columbia Team with New Board-Certified Gastroenterologists
09/01/2026 -
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering
09/01/2026 -
Most Popular SARMS for Bulking, Muscle Building and Strength 2026: Latest SARM Stacks for Muscle Growth & Bodybuilding - CrazyBulk
09/01/2026 -
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/01/2026 -
Virbac : Declaration of the number of shares and voting rights 12/2025
09/01/2026 -
Virbac : Déclaration d'actions et de droits de vote 12/2025
09/01/2026 -
Bright Minds Biosciences Announces Closing of US$175 Million Public Offering
09/01/2026 -
Disclosure of notification received from BNP Paribas
09/01/2026 -
Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference
09/01/2026 -
Angels My Way Home Care Celebrates 15th 5-Star Google Review, Reinforcing Role as Best Home Health Care Service in Hamilton, Ontario
09/01/2026 -
SEED Therapeutics Doses First Patient in Phase 1 Trial of ST-01156, a Molecular Glue Degrader Targeting RBM39
09/01/2026 -
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment
09/01/2026 -
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment
09/01/2026 -
Community Mental Health Association of Michigan Applauds Court of Claims Ruling on MDHHS Mental Health Bidout Process
09/01/2026 -
ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research
09/01/2026 -
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
09/01/2026 -
Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026
09/01/2026 -
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Alamar Biosciences for the Transformative Bio-Hermes Studies
09/01/2026
Pages